By admin 
The findings from this pivotal study indicate a complex interplay between dietary components and genetic predisposition. Specifically, the research highlights that saturated fat, a nutrient that can constitute a larger proportion of calories in some low-carb diets due to increased consumption of animal products and certain fats, may interact critically with a person’s unique genetic blueprint. This interaction, the study posits, can significantly elevate LDL cholesterol, a well-established and major contributor to the risk of developing heart disease and atherosclerotic cardiovascular disease. This genetic influence provides a compelling explanation for why two individuals, meticulously following what appears to be a similar low-carbohydrate dietary regimen, can exhibit dramatically different and often contradictory cholesterol responses.
"Our findings suggest that some individuals may be inherently more sensitive to the LDL cholesterol-raising effects of saturated fat, especially when consuming a low-carbohydrate diet, precisely because of their distinct genetic background," explained Alexa Barad, PhD, RDN, a postdoctoral scholar at Stanford University School of Medicine, who spearheaded this research. Dr. Barad’s presentation at NUTRITION 2026 underscored the profound implications of these findings for personalized nutrition and preventative healthcare.
"These findings powerfully highlight that there is real, measurable heterogeneity in how different people respond to dietary interventions," Dr. Barad emphasized during her presentation. "Dietary conversations, unfortunately, can sometimes become overly simplified and polarized. One person might confidently assert, ‘Low-carb diets always raise LDL cholesterol,’ based on their experience or observations, while another vehemently counters, ‘My LDL cholesterol did not change at all,’ reflecting their own reality. Our research strongly suggests that both of these seemingly contradictory experiences can, in fact, be entirely true, depending, at least in part, on the individual’s unique genetic makeup." This statement encapsulates the study’s core message: dietary advice cannot be a universal mandate but must instead consider individual biological variability.
Why Low-Carb Diets Affect People Differently: Unpacking the Genetic Link
Low-carbohydrate diets, which typically restrict carbohydrate intake to varying degrees, from very low (e.g., ketogenic diets) to moderate, have surged in popularity over the past two decades. Proponents often advocate for their potential benefits in weight management, particularly for initial rapid weight loss, and in improving metabolic markers such as blood sugar control for individuals with type 2 diabetes or insulin resistance. These diets operate on the principle of shifting the body’s primary fuel source from carbohydrates to fat, often leading to a state of ketosis. While initial research and anecdotal evidence have supported these positive outcomes for some individuals, their long-term impact on cardiovascular health, especially concerning lipid profiles, has remained a subject of intense scientific debate and often inconsistent findings.
Earlier research, including various observational studies and smaller clinical trials, has indeed found that healthy low-carbohydrate diets can be effective for some individuals seeking to lose weight and achieve better glycemic control. However, the impact of these diets on LDL cholesterol, a critical biomarker for heart disease risk, has been notoriously inconsistent across studies and individuals. This variability has posed a significant challenge for clinicians and nutritionists attempting to provide clear, evidence-based dietary recommendations. It also fueled the researchers’ motivation to delve deeper, specifically to determine whether genetic information could serve as a predictive tool to identify individuals who are most likely to benefit from reducing carbohydrate intake versus those who might instead experience a potentially dangerous and clinically significant rise in LDL cholesterol, thereby increasing their risk of cardiovascular events.
To explore this complex interaction, the researchers meticulously analyzed data from the DIETFITS trial, a landmark randomized controlled trial. The original DIETFITS study, which involved more than 600 adults, was designed to compare the efficacy of a healthy low-carbohydrate diet against a healthy low-fat diet over a one-year period, primarily focusing on weight loss outcomes. A key initial finding from the original trial was that neither diet demonstrated a significant advantage over the other when it came to overall weight loss, suggesting that sustained dietary adherence and caloric deficit might be more critical than the specific macronutrient composition for general weight reduction.
For the purpose of this novel analysis, the researchers honed in on a subset of 431 DIETFITS participants for whom comprehensive genetic data were readily available. This allowed them to conduct a sophisticated examination of the intricate relationships between several key variables: individual genotype, the level of saturated fat consumption, the type of diet followed (low-carb vs. low-fat), and the observed changes in LDL cholesterol levels from the baseline measurement to the 6-month follow-up point. This robust methodological approach aimed to disentangle the factors contributing to the diverse cholesterol responses.
Genetics and Saturated Fat: A Potent Link to LDL Increases
The core of the study’s revelation lay in its findings among participants who were assigned to the low-carbohydrate diet group. Within this cohort, individuals who possessed a genetic predisposition towards higher LDL cholesterol levels were significantly more likely to experience a noticeable and often substantial increase in their LDL cholesterol. This finding alone was impactful, but the researchers pushed further to understand the underlying mechanism.
Their analysis revealed that a greater sensitivity to saturated fat intake appeared to be the primary driver behind this observed pattern. Specifically, participants who exhibited the highest genetic risk for elevated LDL cholesterol showed the largest and most pronounced increases in their LDL levels when their consumption of saturated fat was higher within the context of their low-carbohydrate diet. Crucially, the same direct and statistically significant relationship between genetic risk, saturated fat intake, and LDL increases was not observed among individuals following the low-fat diet, underscoring the specific interaction at play within the low-carb framework. This suggests that the metabolic environment created by a low-carbohydrate diet might amplify the genetic predisposition to saturated fat’s LDL-raising effects.
A significant methodological advancement in this research was the approach to genetic analysis. Instead of examining only individual genetic variants, a common practice in many previous genetic association studies which often yield limited predictive power due to the polygenic nature of complex traits, the researchers employed a more comprehensive strategy. They combined information from thousands of distinct genetic variants distributed across the entire human genome. This intricate aggregation of genetic data allowed them to create what is known as a polygenic score. This polygenic score provided a more robust and holistic estimate of each participant’s overall genetic tendency toward either higher or lower LDL cholesterol levels, offering a more powerful predictive tool than single gene markers.
Dr. Barad articulated the profound future implications of this methodology, suggesting that such polygenic scores could eventually become invaluable tools for clinicians. In the future, these scores could potentially help healthcare providers identify individuals who are at a higher risk of experiencing unfavorable cholesterol changes, or indeed other adverse metabolic responses, following specific dietary modifications, thereby enabling truly personalized dietary guidance.
Monitoring Cholesterol May Matter More Than Following One Rule
While the advent of polygenic scores and advanced genetic testing holds immense promise for the future of personalized medicine, Dr. Barad emphasized that practical lessons can be drawn from these findings immediately, even without requiring sophisticated genetic testing. The most salient takeaway is the unequivocal evidence that people can, and indeed do, respond dramatically differently to what appears to be the same dietary change. This inherent biological variability underscores the critical importance of a personalized approach to nutrition. Rather than rigidly adhering to a generalized dietary rule or assuming that a particular diet will yield uniform results for everyone, it becomes paramount to monitor how an individual’s unique body responds to dietary interventions. Regular check-ups, including lipid panels, are essential for anyone embarking on significant dietary changes, especially those involving macronutrient shifts.
Additional research will be indispensable to confirm these compelling results and to ascertain whether they apply broadly across more diverse populations. The DIETFITS trial participants, while numerous, may not fully represent the vast genetic and ethnic diversity of the global population. Future studies involving larger, more heterogeneous cohorts will strengthen the generalizability and clinical applicability of these findings.
Current established dietary guidance from major health organizations generally recommends keeping saturated fat intake below 10% of daily caloric intake, with some guidelines suggesting even lower, around 5-6% for individuals at higher cardiovascular risk. Furthermore, these guidelines strongly advocate for choosing unsaturated fats—both monounsaturated and polyunsaturated—whenever possible, as they are known to have beneficial effects on cholesterol levels. For individuals who conscientiously choose to follow a low-carbohydrate diet, Dr. Barad offered concrete and actionable advice. She suggested a deliberate emphasis on incorporating sources of healthy, unsaturated fats into their diet, such as nuts, seeds, olive oil, and avocados. Conversely, she advised minimizing the consumption of foods notoriously rich in saturated fat, which commonly include butter, beef tallow, fatty cuts of red and processed meats, and certain dairy products. By making these informed dietary choices, low-carb dieters may significantly help to lower their individual risk of experiencing an unfavorable and potentially dangerous cholesterol response. This pragmatic approach blends the principles of low-carbohydrate eating with sound cardiovascular health strategies, allowing individuals to potentially reap the benefits of their chosen diet while mitigating associated risks.
The DIETFITS trial, which provided the foundational data for this insightful analysis, was generously funded by grant 1R01DK091831 from the National Institute of Diabetes and Digestive and Kidney Diseases; grants 1K12GM088033 and T32HL007034 from the National Heart, Lung, and Blood Institute; and the Stanford Clinical and Translational Science Award, grant UL1TR001085 from the National Institutes of Health. Dr. Alexa Barad’s pivotal work on this study was supported by the prestigious American Heart Association Postdoctoral Fellowship (26POST1542318). It is important to note that the content presented is solely the responsibility of the authors and does not necessarily represent the official views or endorsements of the National Institutes of Health or any other funding organizations.
Please be advised that abstracts presented at NUTRITION 2026, while rigorously evaluated and selected by a committee of expert scientists, have not typically undergone the exhaustive peer-review process that is a standard requirement for publication in a scientific journal. As such, the findings presented herein should be considered preliminary until a fully peer-reviewed publication of this research becomes publicly available. This caveat is standard practice for reporting on cutting-edge research presented at scientific conferences.
